Mohamed El-Mawardy

TL;DR: Among patients with high-risk aortic stenosis undergoing TAVR, the use of a balloon-expandable valve resulted in a greater rate of device success than use ofA self-expanded valve, including all-cause mortality, major stroke, and other serious complications.

TL;DR: Clinical transcatheter heart valve thrombosis is more common than previously considered, characterized by imaging abnormalities and increased gradients and N-terminal pro-brain natriuretic peptide levels and Randomized control trials are needed to define optimal antithrombotic therapy aftertranscatheter aortic valve replacement.

TL;DR: Lesion preparation with upfront RA before drug-eluting stent implantation is feasible in nearly all patients with severely calcified coronary lesions, is more commonly successful as a primary strategy compared with MB, and is not associated with excessive late lumen loss.

TL;DR: Despite the higher device success rate with the balloon-expandable valve, 1-year follow-up of patients in CHOICE revealed clinical outcomes after transfemoral transcatheter aortic valve replacement with both balloon- and self-Expandable prostheses that were not statistically significantly different.

TL;DR: Five-year follow-up of patients in the CHOICE trial revealed clinical outcomes after transfemoral transcatheter aortic valve replacement with early-generation BE and SE valves that were not statistically significantly different, with limited statistical power.